M3 Inc
TSE:2413

Watchlist Manager
M3 Inc Logo
M3 Inc
TSE:2413
Watchlist
Price: 1 425 JPY -0.87% Market Closed
Market Cap: 967.6B JPY
Have any thoughts about
M3 Inc?
Write Note

Gross Margin
M3 Inc

57.5%
Current
59%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.5%
=
Gross Profit
142.6B
/
Revenue
247.9B

Gross Margin Across Competitors

Country JP
Market Cap 967.6B JPY
Gross Margin
58%
Country US
Market Cap 35B USD
Gross Margin
73%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 23.2B AUD
Gross Margin
100%
Country US
Market Cap 9B USD
Gross Margin
90%
Country US
Market Cap 5.7B USD
Gross Margin
85%
Country US
Market Cap 5.4B USD
Gross Margin
67%
Country SE
Market Cap 53.1B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.4B CNY
Gross Margin
43%
Country US
Market Cap 2.1B USD
Gross Margin
41%
No Stocks Found

M3 Inc
Glance View

Market Cap
967.6B JPY
Industry
Health Care

M3 Inc., a pioneering force in healthcare information services, has carved a niche for itself by leveraging deep insights and technological innovation to enhance medical communication and research. Founded in Japan in 2000, the company developed a robust platform that connects healthcare professionals with pharmaceutical companies, facilitating the efficient flow of information and ensuring that practitioners have access to the latest medical advancements. This focus on bridging the gap between industry players not only streamlines the dissemination of critical knowledge but also fosters a collaborative ecosystem that drives continuous medical education and patient care improvements. With a blend of data analytics and a vast network of professionals, M3 Inc. has successfully positioned itself as a go-to partner for both healthcare providers and drug manufacturers. As the company expanded its operations internationally, it adopted a strategic vision that includes significant investments in technology and data management. M3 Inc. caters to a diverse range of needs within the healthcare sector, from market research to digital marketing solutions. The firm’s innovative approach has led to impressive growth in revenue and a solid market presence across Asia and beyond. For investors, M3 Inc. represents a compelling opportunity, as its business model is designed to capitalize on the ongoing digital transformation of the healthcare industry. With a commitment to delivering substantial value and a clear growth trajectory, M3 Inc. stands poised to play an integral role in shaping the future of healthcare communication and innovation.

Intrinsic Value
2 281.17 JPY
Undervaluation 38%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.5%
=
Gross Profit
142.6B
/
Revenue
247.9B
What is the Gross Margin of M3 Inc?

Based on M3 Inc's most recent financial statements, the company has Gross Margin of 57.5%.